Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Coya Therapeutics (COYA) Return on Equity (2023 - 2025)

Historic Return on Equity for Coya Therapeutics (COYA) over the last 3 years, with Q3 2025 value amounting to 0.72%.

  • Coya Therapeutics' Return on Equity fell 4000.0% to 0.72% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.72%, marking a year-over-year decrease of 4000.0%. This contributed to the annual value of 0.4% for FY2024, which is 1900.0% up from last year.
  • As of Q3 2025, Coya Therapeutics' Return on Equity stood at 0.72%, which was down 4000.0% from 0.71% recorded in Q2 2025.
  • Coya Therapeutics' Return on Equity's 5-year high stood at 0.29% during Q2 2024, with a 5-year trough of 0.83% in Q3 2023.
  • Over the past 3 years, Coya Therapeutics' median Return on Equity value was 0.46% (recorded in 2024), while the average stood at 0.51%.
  • As far as peak fluctuations go, Coya Therapeutics' Return on Equity skyrocketed by 5200bps in 2024, and later tumbled by -4200bps in 2025.
  • Over the past 3 years, Coya Therapeutics' Return on Equity (Quarter) stood at 0.35% in 2023, then tumbled by -33bps to 0.46% in 2024, then crashed by -56bps to 0.72% in 2025.
  • Its Return on Equity stands at 0.72% for Q3 2025, versus 0.71% for Q2 2025 and 0.51% for Q1 2025.